Citigroup Maintains Buy on Amrize, Lowers Price Target to $66

Benzinga Newsdesk www.benzinga.com Negative 56.5%

Neg 56.5% Neu 0% Pos 0%

Citigroup analyst Anthony Pettinari maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $76 to $66.